Last Week’s Hemp Commentary
Lack of Safety Testing in Cannabinoid Markets
Cannabinoid hemp markets have struggled to gain traction amidst unclear regulation, and paltry demand, in part because a lack of regulatory clarity. Delta-8 THC (∆8) has by far represented the most demand in cannabinoid hemp markets since mid-2020, accounting for thousands of kilos of CBD isolate and other extracts used as feedstock for isomerization to ∆8.
This is a very opaque market, making volume difficult to track. Operators – mostly principals – are reluctant to share ∆8 transactions, given the increasing risk. At least a dozen states have either banned ∆8 or synthetic cannabinoids in recent months, or plan to regulate it like MJ.
Opinions on ∆8 vary in the diverse hemp industry. For operators with a history in cannabis markets, or any financial interest in ∆8 marketing, the product doesn’t raise eyebrows as much…
Membership is required to view the rest of this post.
Click here to learn more and sign up for a free 7-day trial!